Open Orphan Plc is a contract research organization (CRO), which provides the testing of infectious and respiratory disease products through clinical trials. The company’s Venn Life Sciences’ clinical research division offers a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organisations. Its service areas include – clinical pharmacokinetics (PK) and pharmacometrics, non-clinical development consultancy, chemistry, manufacturing, and controls (CMC) consultancy, medical writing and regulatory affairs; data management, statistics, study design and methodology, and data services for rare diseases. Its hVIVO clinical trial platform carries out drug and vaccine development in respiratory and infectious diseases. hVIVO facilitates product development for customers developing antivirals, vaccines, and respiratory therapeutics. The company’s portfolio of challenge study models includes influenza, respiratory syncytial virus (RSV), human rhinovirus (hRV), asthma, cough, chronic obstructive pulmonary disease (COPD), malaria, and Covid-19.